Invesaro

Stocks NSC Financial statements

Financial statements

NORFOLK SOUTHERN CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NORFOLK SOUTHERN CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue9,88810,55111,45811,2969,78911,14212,74512,15612,12312,180
Operating expenses6,8797,0297,499
Operating income3,0093,5223,9593,9893,0024,4474,8092,8514,0714,356
Interest expense563550557604625646692722807792
Interest income1013
Other non-operating income13615667106153771319165101
Pre-tax income2,5823,1283,4693,4912,5303,8784,1302,3203,3293,665
Income tax914-2,276803769517873860493707792
Net income1,6635,4042,6662,7222,0133,0053,2701,8272,6222,873
EBITDA4,0394,5815,0635,1284,1565,6286,0304,1495,4245,749
EPS, basic5.6618.769.5810.327.8812.1613.928.0411.5812.76
EPS, diluted5.6218.619.5110.257.8412.1113.888.0211.5712.75
Shares, basic (weighted)294288278263255247235227226225
Shares, diluted (weighted)296290280266257248236227226225
Dividend per share2.362.443.043.603.764.164.965.405.405.40

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents9566903585801,1158394561,5681,6411,530
Receivables9459551,0099208489761,1481,1471,069988
Other current assets133282288337134134150292201409
Total current assets2,2912,1491,8622,0812,3182,1672,0073,2713,1883,198
Property, plant and equipment29,75130,33031,09131,61431,34531,65332,15633,32635,83136,479
Lease right-of-use assets539433411407390271218
Long-term investments2,7772,9813,1093,4283,5903,7073,6943,8393,3704,089
Other non-current assets732511778007099661,0281,2161,2931,470
Total assets34,89235,71136,23937,92337,96238,49338,88541,65243,68245,236
Accounts payable1,2151,4011,5051,4281,0161,3511,2931,6381,7041,863
Short-term debt5506005853165795537034555607
Total current liabilities2,3392,5452,5912,3002,1602,5212,6492,6323,5453,775
Long-term debt9,5629,13610,56011,88012,10213,28714,47917,17516,65116,480
Lease liabilities0441344331316287191148
Other non-current liabilities1,4421,3471,2661,7441,9871,8791,7591,8391,7601,723
Total liabilities22,48319,35220,87722,73923,17124,85226,15228,87129,37629,689
Total debt10,1129,73611,14512,19612,68113,84015,18217,17917,20617,087
Paid-in capital2,1792,2542,2162,2092,2482,2152,1572,1792,2472,296
Retained earnings10,42514,17613,44013,20712,88311,58610,69710,69512,09313,235
Treasury stock-19-19-19-19-19-19-19-19-19-19
Other comprehensive income-487-356-563-491-594-402-351-320-262-210
Shareholders' equity12,40916,35915,36215,18414,79113,64112,73312,78114,30615,547
Total equity12,40916,35915,36215,18414,79113,64112,73312,78114,30615,547
Total liabilities and equity34,89235,71136,23937,92337,96238,49338,88541,65243,68245,236
Shares outstanding290284268258252240228226226224

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1,6685,4042,6662,7222,0133,0053,2701,8272,6222,873
Depreciation and amortization1,0301,0591,1041,1391,1541,1811,2211,2981,3531,393
Stock-based compensation42454753285453404063
Deferred income tax227-2,85917333014218483-49176277
Change in receivables23-41-708771-133-171-28559
Cash from operations3,0343,2533,7263,8923,6374,2554,2223,1794,0524,361
Capital expenditures-1,887-1,723-1,951-2,019-1,494-1,470-1,948-2,327-2,381-2,204
Purchases of investments-123-7-10-18-13-10-12-124-319-621
Cash from investing-1,832-1,481-1,658-1,764-1,175-1,222-1,603-2,182-2,780-2,562
Stock issued741045853984225194117
Share buybacks-803-1,012-2,781-2,099-1,439-3,390-3,110-6220-534
Dividends paid-695-703-844-949-960-1,028-1,167-1,225-1,221-1,215
Cash from financing-1,347-2,038-2,312-1,994-1,927-3,309-3,002115-1,199-1,910
Net change in cash-145-266-244134535-276-3831,11273-111
Free cash flow1,1471,5301,7751,8732,1432,7852,2748521,6712,157
Interest paid543528496555577579619653764765
Income taxes paid593705519543311654750681305491

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $313.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin32.2%Operating income / revenue.
EBITDA margin43.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin26.8%Pre-tax income / revenue.
Net margin21.0%Net income / revenue.
FCF margin13.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin29.8%Cash from operations / revenue.
Effective tax rate21.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)16.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.8%Net income / average total assets.
Return on invested capital (ROIC)9.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue16.8%Capital expenditures / revenue.
D&A / revenue11.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y7.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-3.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y6.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-1.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y6.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y9.6%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-4.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y7.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y10.2%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-2.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y10.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y7.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y1.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y3.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y29.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-1.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y0.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y2.9%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y7.5%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y8.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y6.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y1.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y3.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.6%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.83xCurrent assets / current liabilities.
Quick ratio0.67x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.32x(Cash + short-term investments) / current liabilities.
Debt / equity1.02xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets36.8%Total debt / total assets.
Liabilities / assets64.0%Total liabilities / total assets.
Net debt$15.55BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.85xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.13xOperating income / interest expense.
Working capital-$569.0MCurrent assets - current liabilities.
Tangible book value$16.25BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.28xRevenue / average total assets.
Fixed asset turnover0.34xRevenue / average property, plant and equipment.
Receivables turnover10.7xRevenue / average receivables.
Days sales outstanding34 days365 x average receivables / revenue.
FCF conversion61.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow56.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$11.72Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$55.73Revenue / diluted weighted shares.
FCF per share$7.25Free cash flow / diluted weighted shares.
Operating cash flow per share$16.59Cash from operations / diluted weighted shares.
Book value per share$72.36Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$72.36Tangible book value / shares outstanding.
Cash per share$4.76(Cash + short-term investments) / shares outstanding.
Payout ratio46.0%Dividends paid / net income, when net income is positive.
Dividends / FCF74.3%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF5.1%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$70.30BShare price x shares outstanding.
Enterprise value$85.85BMarket cap + total debt - cash - short-term investments.
P/E26.7xMarket cap / net income. Only when net income is positive.
P/S5.61xMarket cap / revenue.
P/B4.33xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.33xMarket cap / tangible book value, when positive.
P/FCF43.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF18.8xMarket cap / cash from operations, when positive.
EV/Sales6.85xEnterprise value / revenue.
EV/EBIT21.3xEnterprise value / operating income, when both are positive.
EV/EBITDA15.8xEnterprise value / EBITDA, when both are positive.
EV/FCF52.6xEnterprise value / free cash flow, when both are positive.
FCF yield2.3%Free cash flow / market cap.
Earnings yield3.7%Net income / market cap (the inverse of P/E).
Dividend yield1.7%Dividends paid over the period / market cap.
Shareholder yield1.8%(Dividends paid + share buybacks) / market cap.
What was NORFOLK SOUTHERN CORP's revenue in fiscal 2025?

NORFOLK SOUTHERN CORP reported revenue of $12.18B for fiscal 2025, 0.5% higher than the year before.

Was NORFOLK SOUTHERN CORP profitable in fiscal 2025?

Yes. Net income was $2.87B, a net margin of 23.6%.

How much free cash flow did NORFOLK SOUTHERN CORP generate in fiscal 2025?

Cash from operations of $4.36B minus capital expenditures of $2.20B left free cash flow of $2.16B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NORFOLK SOUTHERN CORP